keyword
https://read.qxmd.com/read/37394253/anaphylaxis-after-the-emergency-department
#21
REVIEW
Nicholas P Gorham
After treating the acute anaphylactic reaction, the clinician's next task is to prevent a recurrence. The patient should be observed in the ED. How long this observation period should last depends on their clinical course, risk factors, and social support. All patients should be discharged with a prescription for 2 epinephrine autoinjectors and counseled on appropriate use. The patient should also receive education on the signs and symptoms of anaphylaxis and avoiding triggers. The patient should follow-up with an allergy specialist who can confirm triggers and provide immunotherapy as indicated...
August 2023: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/37394178/fast-acting-dry-powder-needle-free-intranasal-epinephrine-spray-a-promising-future-treatment-for-anaphylaxis
#22
JOURNAL ARTICLE
Yuval Tal, Yaarit Ribak, Limor Rubin, Aviv Talmon, Oded Shamriz, Alon Y Hershko, Simcha Blotnick, Mohammed Bouhajib, Galia Temtsin Krayz, Carolina Abrutzky, Dalia Megiddo, Tair Lapidot, Yoseph Caraco
BACKGROUND: Epinephrine intramuscular (IM) autoinjector is a life-saving drug for the emergency treatment of immediate-type allergic reactions (type I). Nevertheless, it is sometimes applied incorrectly or underused because of short shelf life, high costs, fear of use, or inconvenience of carrying. FMXIN002, a nasal powder spray of epinephrine, was developed as a needle-free alternative. OBJECTIVE: To compare epinephrine pharmacokinetics, pharmacodynamics, and safety after the administration of the FMXIN002 nasal spray versus autoinjector...
October 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/37358800/variation-in-the-guidelines-for-the-acute-management-of-anaphylaxis-in-pediatric-patients-an-international-narrative-review
#23
JOURNAL ARTICLE
Sofia Grigoria Athanasopoulou, Stephanie Leeds, Marc Auerbach
OBJECTIVES: Evidence-based guidelines have been created and disseminated by multiple organizations to standardize the care of pediatric patients with anaphylaxis. Differences across these guidelines can cause confusion and potentially errors in clinical practice leading to patient harm. The aim of this study was to describe and identify patterns of variation in the current guidelines. METHODS: A narrative review with 3 major components was designed. First, a narrative review of current, peer-reviewed, guidelines published by national and international allergy and immunology, pediatric, and emergency medicine organizations was performed...
June 26, 2023: Pediatric Emergency Care
https://read.qxmd.com/read/37314805/racial-ethnic-and-socioeconomic-differences-in-food-allergies-in-the-us
#24
JOURNAL ARTICLE
Jialing Jiang, Christopher M Warren, Audrey Brewer, Gary Soffer, Ruchi S Gupta
IMPORTANCE: Food allergies affect approximately 8% of children and 11% of adults in the US. Racial differences in food allergy outcomes have previously been explored among Black and White children, but little is known about the distribution of food allergies across other racial, ethnic, and socioeconomic subpopulations. OBJECTIVE: To estimate the national distribution of food allergies across racial, ethnic, and socioeconomic groups in the US. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional survey study, conducted from October 9, 2015, to September 18, 2016, a population-based survey was administered online and via telephone...
June 1, 2023: JAMA Network Open
https://read.qxmd.com/read/37279803/innovations-in-the-treatment-of-anaphylaxis-a-review-of-recent-data
#25
REVIEW
Jay A Lieberman, John Oppenheimer, Vivian P Hernandez-Trujillo, Michael S Blaiss
PURPOSE OF REVIEW: The current standard of first-line emergency treatment of anaphylaxis is intramuscular (IM) epinephrine, mostly administered through epinephrine autoinjector (EAI) in the outpatient setting. However, undercarriage and underuse of EAIs are common, and delayed epinephrine use is associated with increased morbidity and mortality. Patients, caregivers, and healthcare professionals have expressed a strong desire for small, needle-free devices and products that would offer improved carriage, ease of use, and more convenient, less invasive routes of epinephrine administration...
August 2023: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/37277272/retrieval-of-additional-doses-of-epinephrine-from-the-new-teva-epinephrine-autoinjector-pen
#26
JOURNAL ARTICLE
Alexander J Axtell, Carver M Haines, Tyler J Stannard
Epinephrine autoinjectors are commonly used in urban environments for anaphylaxis. In remote environments, the effects of a single dose of epinephrine may diminish before one can access higher medical care. By retrieving additional epinephrine from common autoinjectors, a medical provider may be able to treat or delay decompensation of anaphylaxis in the field during evacuation. The new Teva epinephrine autoinjectors were obtained. The design of the mechanism was researched by studying patents and disassembling trainers and medication-containing autoinjectors...
June 3, 2023: Wilderness & Environmental Medicine
https://read.qxmd.com/read/37172716/refractory-anaphylaxis-a-new-entity-for-severe-anaphylaxis
#27
REVIEW
Guillaume Pouessel, Antoine Deschildre, Timothy E Dribin, Ignacio J Ansotegui, Victoria Cardona, R Sharon Chinthrajah, Motohiro Ebisawa, Antonella Muraro, Graham Roberts, Hugh A Sampson, Susan Waserman, Robert A Wood, Margitta Worm, Paul J Turner
Anaphylaxis reactions lie on a spectrum of severity, ranging from relatively mild lower respiratory involvement (depending on the definition of anaphylaxis used) to more severe reactions that are refractory to initial treatment with epinephrine and may rarely cause death. A variety of grading scales exist to characterize severe reactions, but there is a lack of consensus about the optimal approach to define severity. More recently, a new entity called refractory anaphylaxis (RA) has emerged in the literature, characterized by the persistence of anaphylaxis despite initial epinephrine treatment...
July 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/37171671/revisiting-the-definition-of-anaphylaxis
#28
REVIEW
Catherine Hammond
PURPOSE OF REVIEW: Anaphylaxis is a common phenomenon that has been studied for many decades. Despite this, there is still disagreement among organizations regarding the precise definition for anaphylaxis. This article discusses the difference between the proposed definitions of anaphylaxis. Furthermore, the most up-to-date literature on specific subtypes of anaphylaxis is reviewed, and implications for clinical practice are discussed. RECENT FINDINGS: Recent literature on various subtypes of anaphylaxis has been conducted...
May 12, 2023: Current Allergy and Asthma Reports
https://read.qxmd.com/read/37105602/food-allergy
#29
REVIEW
Chelsea Elizabeth Mendonca, Doerthe A Andreae
Food allergy is a growing health problem affecting both pediatric and adult patients. Food allergies are often immunoglobulin E (IgE) mediated but other food-induced non-IgE-mediated diseases exist. Diagnosis of food allergy relies on the combination of clinical and reaction history, skin and IgE testing as well as oral food challenges. Although oral immunotherapy has been able to achieve sustained unresponsiveness in some patients, no cure for food allergies has been found to date. Avoidance of the inciting food as well as availability of epinephrine autoinjectors remains the mainstay of treatment...
June 2023: Primary Care
https://read.qxmd.com/read/37090392/accidental-digital-ischemia-by-an-epinephrine-autoinjector
#30
Mohamed Nayaz, Ahmed Mohamed, Ali Nawaz
Epinephrine is the first line of management of anaphylaxis. Autoinjectors rapidly deliver epinephrine in anaphylaxis in the community. Patients and caregivers have safety concerns regarding their use. Accidental digital injection is a frequently encountered problem that can lead to digital ischemia. Immersion of the affected digit in warm water and topical nitroglycerine are usually used. If the symptoms persist, the patient discomfort and the possible risk of losing the digit might require an invasive approach...
March 2023: Curēus
https://read.qxmd.com/read/36980099/food-allergy-management-competence-in-greek-schools
#31
JOURNAL ARTICLE
Gavriela Feketea, John Lakoumentas, Evangelia Papatriantafyllou, Nikolaos Douladiris, Dimitris Efthymiou, Luminita Aurelia Stanciu, Emilia Vassilopoulou
BACKGROUND: Schoolchildren are likely to consume meals and snacks at school, with a possibility of allergic food reactions and anaphylaxis in the school environment. The school personnel should be informed of the presence of schoolchildren with food allergy (FA) and need to be trained in the management of allergic reactions, as to prepare them to intervene appropriately when necessary. Limited knowledge of FA and its management is documented globally among school staff and there is no uniform protocol in schools...
March 11, 2023: Children
https://read.qxmd.com/read/36882233/food-allergy-knowledge-attitudes-and-beliefs-of-kindergarten-teachers-in-kuwait-a-cross-sectional-study
#32
JOURNAL ARTICLE
Latifah Madooh, Shaikhah Allahou, Haya Alshallal, Fatemah Alkazemi, Dina Alyaseen, Farah Allahow, Shahad Alsattam, Abdullah Al-Majran, Ali H Ziyab
BACKGROUND: Food allergy (FA) affects up to 10% of children globally, with clinical symptoms varying from mild to severe, and in rare instances, it is life-threatening. Approximately one in five children with FA experience a food-induced allergic reaction in school, leaving teachers as the first line of intervention. This study aimed to assess kindergarten teachers' knowledge, attitudes and beliefs regarding FA. METHODS: This cross-sectional study enrolled kindergarten teachers in Kuwait using stratified cluster sampling...
March 2023: BMJ Paediatrics Open
https://read.qxmd.com/read/36798716/a-conceptual-framework-for-instructional-design-of-a-high-acuity-and-low-occurrence-event-simulation-based-education-training-of-residents-medical-students-and-nurses-in-anaphylaxis-utilizing-curated-educational-theories
#33
JOURNAL ARTICLE
Ahmad Hakemi, John Blamoun, Andrew Lundahl, Teresa Armstead, Kelvin Hakemi, Mishaal Malik
The broad goal of this educational curriculum is utilization and optimization of Simulation-Based Education (SBE) in the training of residents, medical students, and nursing staff involved in the rapid and timely recognition of Anaphylaxis and its optimized treatment. A critical gap in Anaphylaxis Diagnosis, Management, and Treatment (ADAM) has been well established across medical disciplines. It is imperative to include all members of the healthcare team, as nurses and pharmacists play key roles in anaphylaxis recognition and care...
2023: Advances in Medical Education and Practice
https://read.qxmd.com/read/36796511/who-needs-epinephrine-anaphylaxis-auto-injectors-and-parachutes
#34
REVIEW
Timothy E Dribin, Susan Waserman, Paul J Turner
International guidelines stipulate that intramuscular (IM) epinephrine (adrenaline) is the first line treatment for anaphylaxis, with an established good safety profile. The availability of epinephrine autoinjectors (EAI) has greatly facilitated the lay-administration of IM epinephrine in community settings. However, key areas of uncertainty remain around epinephrine usage. These include variations in prescribing EAI, what symptoms should prompt epinephrine administration, whether Emergency Medical Services need to be contacted after administration, and whether epinephrine administered via EAI reduces mortality from anaphylaxis or improves quality of life measures...
February 14, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/36794963/optimal-dose-of-adrenaline-auto-injector-for-children-and-young-people-at-risk-of-anaphylaxis-a-phase-iv-randomized-controlled-crossover-study
#35
JOURNAL ARTICLE
Nandinee Patel, Emily Isaacs, Bettina Duca, Nanthagopan Nagaratnam, Jackie Donovan, Sara Fontanella, Paul J Turner
BACKGROUND: Guidelines recommend intramuscular injection of 500 μg adrenaline (epinephrine) for anaphylaxis in teenagers and adults; however, most autoinjectors deliver a maximum 300 μg dose. We evaluated plasma adrenaline levels and cardiovascular parameters (including cardiac output) following self-injection with 300 μg or 500 μg adrenaline in teenagers at risk of anaphylaxis. METHODS: Subjects were recruited to a randomized, single-blind two period crossover trial...
February 16, 2023: Allergy
https://read.qxmd.com/read/36719691/epinephrine-autoinjectors-individualizing-device-and-dosage-to-optimize-anaphylaxis-management-in-the-community-setting
#36
JOURNAL ARTICLE
Harold Kim, Reza Alizadehfar, Waleed Alqurashi, Anne K Ellis, David A Fischer, Hannah Roberts, Bahar Torabi, Susan Waserman
Background: Anaphylaxis is the most severe manifestation of a systemic allergic reaction, and, in the community setting, the immediate administration of an epinephrine autoinjector (EAI) can be life-saving. Physicians are tasked with selecting the most appropriate EAI for each individual and counseling patients and/or their caregivers to maximize the likelihood of successful deployment of the EAI. Objective: To offer an evidence-based expert clinical perspective on how physicians might best tailor EAI selection to their patients with anaphylaxis...
January 1, 2023: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/36719689/anaphylaxis-long-term-management-and-resources
#37
REVIEW
Aishwarya Navalpakam, Narin Thanaputkaiporn, Pavadee Poowuttikul
Background: Anaphylaxis is an acute life-threatening event that requires emergent diagnosis and treatment. However, focus on prevention of anaphylaxis is essential in reducing anaphylaxis recurrences and associated mortality. Objective: This literature review was aimed to be a comprehensive resource for practicing allergists in managing anaphylaxis in the long term. We discussed the role of the allergist in the long-term outpatient management of anaphylaxis through identifying risk factors, allergen avoidance, prevention of recurrences, and patient education...
January 1, 2023: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/36716996/evaluating-the-food-allergy-passport-a-novel-food-allergy-clinical-support-tool
#38
JOURNAL ARTICLE
Ashley Ciliberti, Justin Zaslavsky, Tegan Morcott, Alexandria Bozen, Waheeda Samady, Lisa Lombard, Sai Nimmagadda, Kari Nadeau, Ruchi Gupta, Mary Tobin
BACKGROUND: Pediatric food allergy (FA) prevalence has increased in the last two decades and previous literature suggests FA presents burdens, both economically and psychosocially, to children and their caregiver(s), especially families in lower-income strata. Using data from a previously published needs assessment, the Food Allergy Management In Low-income Youth (FAMILY) study, the FA Passport and Workbook tools were developed to address identified needs. OBJECTIVE: This study evaluated the utility of the FA Passport in helping families insured by Medicaid to better manage FA and improve quality of life...
January 27, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/36564222/symjepi-epinephrine-injection-device-deconstruction-and-residual-medication-retrieval-in-an-austere-environment
#39
JOURNAL ARTICLE
Braden J Tucker, Luke He, Aimee Mishler, Geoffrey B Comp
Epinephrine is the primary therapy in the treatment of anaphylaxis. Epinephrine delivery devices are commonplace in out-of-hospital care of anaphylaxis because they administer a standardized dose of epinephrine, limit human error, and allow for ease of use by the operator. However, a major limitation of these devices is the single-use nature of the products. In an austere setting, the ability to obtain additional doses from an autoinjector may prevent further progression of anaphylaxis. Previous articles have demonstrated the deconstruction of spring-loaded epinephrine autoinjectors to extract additional medication doses...
December 21, 2022: Wilderness & Environmental Medicine
https://read.qxmd.com/read/36334720/pharmacokinetic-and-pharmacodynamic-comparison-of-epinephrine-administered-intranasally-and-intramuscularly-an-integrated-analysis
#40
JOURNAL ARTICLE
Sarina Tanimoto, Michael Kaliner, Richard F Lockey, Motohiro Ebisawa, Luana Pesco Koplowitz, Barry Koplowitz, Richard Lowenthal
BACKGROUND: Manual intramuscular epinephrine injection is the standard of care for treating severe allergic reactions and anaphylaxis. Epinephrine autoinjectors were approved based on the assumption that their pharmacokinetic and pharmacodynamic profiles are equivalent to manual intramuscular injection, however while there is emerging evidence for product-related differences in pharmacokinetic profiles, very little is known about the comparative pharmacodynamic profiles. OBJECTIVE: To compare pharmacokinetic and pharmacodynamic profiles of epinephrine delivered via manual intramuscular injection, autoinjectors, and intranasal spray...
November 2, 2022: Annals of Allergy, Asthma & Immunology
keyword
keyword
69507
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.